racemetirosine has been researched along with Brain Disorders in 3 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, XG | 1 |
| Schmidt, N | 1 |
| Teismann, P | 1 |
| Ferger, B | 1 |
| Schulz, JB | 1 |
| de Yebenes, JG | 1 |
| Fahn, S | 1 |
| Jackson-Lewis, V | 1 |
| Jorge, P | 1 |
| Mena, MA | 1 |
| Reiriz, J | 1 |
| Commins, DL | 1 |
| Seiden, LS | 1 |
3 other studies available for racemetirosine and Brain Disorders
| Article | Year |
|---|---|
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Benzazepines; Brain Diseases; Carbido | 2001 |
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
Topics: alpha-Methyltyrosine; Animals; Brain Diseases; Catheterization; Cerebral Ventricles; Disease Models, | 1988 |
alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex.
Topics: alpha-Methyltyrosine; Animals; Brain Diseases; Male; Methamphetamine; Methyltyrosines; Norepinephrin | 1986 |